Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-30

Clinical Trial Update: Glufast On Insulin Glargine Trial in Type 2 DM [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Glufast (insulin glargine) in adults with type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glufast (insulin glargine)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED